标题:Drug delivery systems targeting tumor-associated fibroblasts for cancer immunotherapy
作者:Liu, Mengrui; Song, Wantong; Huang, Leaf
作者机构:[Liu, Mengrui; Huang, Leaf] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacoengn & Mol Pharmaceut, Chapel Hill, NC 27559 USA.; [Liu, Mengrui] Shand 更多
通讯作者:Huang, L
通讯作者地址:[Huang, L]Univ N Carolina, Eshelman Sch Pharm, Div Pharmacoengn & Mol Pharmaceut, Chapel Hill, NC 27559 USA.
来源:CANCER LETTERS
出版年:2019
卷:448
页码:31-39
DOI:10.1016/j.canlet.2019.01.032
关键词:Tumor-associated fibroblasts; Drug delivery; Nanomedicine; Tumor; microenvironment; Cancer immunotherapy; Desmoplastic tumor
摘要:Solid tumors especially desmoplastic tumors are complex organ-like structures. Tumor-associated fibroblasts (TAFs), one type of the stromal cells, support the initiation, progression, and metastasis of carcinomas. TAFs also contribute to immunosuppressive tumor microenvironment (TME) and hinder T lymphocytes in killing tumors. Here, the role of TAFs in TME is discussed. In specific, TAFs form barriers for the penetration of T lymphocytes. TAFs also act as negative regulators for T lymphocytes. These findings suggest that targeting TAFs is a promising strategy for improving cancer immunotherapy. Our previous studies have indicated the ability of therapeutic nanoparticles to distribute into, and deplete or inactivate TAFs. This approach is discussed in the context of developing specific and effective immunotherapies for cancer.
收录类别:SCOPUS;SCIE
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061350291&doi=10.1016%2fj.canlet.2019.01.032&partnerID=40&md5=3861a8cc7360d089c47daf6f17343133
TOP